EPS outlook for NIFTY FY24.
India Inc. has started the financial year 2023-2024 on a strong note, reporting robust results for the April-June 2023 quarter. Here are the key highlights of corporate earnings for the…
India Inc. has started the financial year 2023-2024 on a strong note, reporting robust results for the April-June 2023 quarter. Here are the key highlights of corporate earnings for the…
Life Insurance Corporation of India (LICI), the state-run insurance giant, released its financial results for the quarter ended June 30, 2023. Here's a summary of the key points from the…
CESC Ltd reported strong financial results in Q1FY24. CESC Ltd, a Kolkata-based power utility company, reported strong financial results for the June quarter of 2023-24. Here's an analysis of the…
L&T Finance Holdings Ltd reported its Q1FY24 earnings, showcasing significant growth in revenue and profits. Here's an analysis of the key highlights from the earnings report: Revenue Growth: L&T Finance's…
National Aluminium Co. (NALCO), an aluminium producer, reported its Q1FY24 earnings, revealing a decline in consolidated profit. Here's an analysis of the key highlights from the earnings report: Net Profit…
ICICI Lombard General Insurance, a private sector non-life insurer, reported its Q1FY24 earnings with notable improvements in net profit and premium growth. Here's an analysis of the key highlights from…
Impact of Rising Rates and Inflation on Indian Companies and Banks S&P Global Ratings has indicated that the rising interest rates and inflation in India could have implications for companies…
India Inc Q1FY24 results profit surges 65% but shows growth on slope. The April-June 2023 quarter (Q1FY24) has witnessed a sharp recovery in headline corporate earnings compared to previous quarters.…
Muthoot Finance, a prominent gold financing company in India, reported its financial results for the first quarter ended June 30. Here's an analysis of the company's performance: Profit Growth: Muthoot…
Divis Laboratories, a pharmaceutical company specializing in the manufacture of Active Pharmaceutical Ingredients (APIs) and Intermediates, released its Q1FY24 financial results, showcasing notable performance in various aspects. Here's an analysis…